Objective Hepatocellular carcinoma (HCC) is a major cause of death worldwide and its
incidence is expected to increase globally. Aim of this study was to assess whether the …

Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver and has an
overall five-year survival rate of less than twenty percent. For patients with unresectable …

Background: Delays in diagnosis and treatment have been reported for many cancers, with
resultant stage migration and worse survival; however, few data exist in patients with …

Background and aims Susceptibility to fatty liver disease (FLD) varies among individuals
and between racial/ethnic groups. Several genetic variants influence FLD risk, but whether …

Background: This study aimed to evaluate the updated disease burden, risk factors, and
temporal trends of liver cancer based on age, sex, and country. Methods: We estimated the …

Background and Aims Hepatocellular carcinoma (HCC) is the fastest rising cause of cancer-
related death in the United States; however, HCC incidence and mortality are not equally …

Background & Aims The main causes of hepatocellular carcinoma (HCC) include chronic
hepatitis C and B viral infections (HCV, HBV), nonalcoholic fatty liver disease (NAFLD), and …

Conclusions Immunotherapy was associated with improved OS compared with
chemotherapy in advanced HCC. There are significant disparities in early access to …

Hepatocellular carcinoma (HCC) disproportionately affects racial, ethnic, and low
socioeconomic status (SES) populations. However, the interaction between race, ethnicity …

Importance Racial disparities in liver transplant (LT) for hepatocellular carcinoma (HCC)
may be associated with unequal access to life-saving treatment. Objective To quantify racial …